Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation

American Journal of Clinical Pathology

Volumn 129, Issue 4, 2008, Pages 587-591

  Batal, Ibrahim ^a   Zeevi, Adriana ^a   Heider, Amer ^a   Girnita, Alin ^a   Basu, Amit ^a   Tan, Henkie ^a   Shapiro, Ron ^a   Randhawa, Parmjeet ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

BK virus; Immune cell function; Viremia; Viruria

Indexed keywords

ADENOSINE TRIPHOSPHATE; PHYTOHEMAGGLUTININ; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL FUNCTION; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RISK; VIREMIA; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS REPLICATION; BK VIRUS; DRUG EFFECT; IMMUNE DEFICIENCY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RETROSPECTIVE STUDY; T LYMPHOCYTE; URINE; VIROLOGY; VIRUS ACTIVATION; VIRUS LOAD;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BK VIRUS; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIREMIA; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 42949170544     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/23YGPB1E758ECCFP     Document Type: Article

References (24)

1. Randhawa PS, Vats A, Shapiro R, et al. BK virus: discovery, epidemiology, and biology. Graft. 2002;2(suppl 5):19-27.
2. Mylonakis E, Goes N, Rubin RH, et al. BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation. 2001;72:1586-1592.
3. Harault de Ligny B, Etienne I, Francois A, et al. Polyomavirusinduced acute tubulo-interstitial nephritis in renal allograft recipients. Transplant Proc. 2000;32:2760-2761.
4. Mathur VS, Olson JL, Darragh TM, et al. Polyomavirusinduced interstitial nephritis in two renal transplant recipients: case reports and review of the literature. Am J Kidney Dis. 1997;29:754-758.
5. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation. 1999;67:103-109.
6. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol. 2002;13:2145-2151.
7. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol. 1999;10:1080-1089.
8. Ahuja M, Cohen EP, Dayer AM, et al. Polyoma virus infection after renal transplantation: use of immunostaining as a guide to diagnosis. Transplantation. 2001;71:896-899.
9. Celik B, Shapiro R, Vats A, et al. Polyomavirus allograft nephropathy: sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transplant. 2003;3:1378-1382.
10. Josephson MA, Williams JW, Chandraker A, et al. Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis. 2006;8:95-101.
11. Vats A, Shapiro R, Randhawa PS, et al. Role of quantitative viral load and cidofovir therapy in the management of BK virus nephropathy. Transplantation. 2003;75:105-112.
12. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renalallograft recipients with viral nephropathy. N Engl J Med. 2000;342:1309-1315.
13. Hernandez-Fuentes MP, Warrens AN, Lechler RI. Immunologic monitoring. Immunol Rev. 2003;196:247-264.
14. Soulillou JP. Immune monitoring for rejection of kidney transplants [editorial]. N Engl J Med. 2001;344:1006-1007.
15. Simon T, Opelz G, Wiesel M, et al. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant. 2003;3:1121-1127.
16. US Department of Health and Human Services. K013169; Cylex Immune Cell Function Assay, April 2, 2002.
17. Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation. 2006;82:663-668.
18. Thai NL, Blisard D, Tom K, et al. Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: correlation between low T-cell responses and infection. Transplantation. 2006;82:1649-1652.
19. Kowalski R, Post D, Schneider MC, et al. Immune function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant. 2003;17:77-88.
20. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55:713-723.
21. Comoli P, Binggeli S, Ginevri F, et al. Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl Infect Dis. 2006;8:86-94.
22. Drummond JE, Shah KV, Saral R, et al. BK virus specific humoral and cell mediated immunity in allogeneic bone marrow transplant recipients. J Med Virol. 1987;23:331-344.
23. Hammer MH, Brestrich G, Andree H, et al. HLA type-independent method to monitor polyoma BK virus - specific CD4 and CD8 T-cell immunity. Am J Transplant. 2006;6:625-631.
24. Gautam A, Morrissey PE, Brem AS, et al. Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder. Pediatr Transplant. 2006;10:613-614.